HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Silvia S Pierangeli Selected Research

Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)

6/2014A prospective open-label pilot study of fluvastatin on proinflammatory and prothrombotic biomarkers in antiphospholipid antibody positive patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Silvia S Pierangeli Research Topics

Disease

29Thrombosis (Thrombus)
04/2015 - 01/2002
28Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
09/2016 - 01/2002
9Systemic Lupus Erythematosus (Libman-Sacks Disease)
09/2016 - 08/2002
7Autoimmune Diseases (Autoimmune Disease)
04/2015 - 11/2007
6Thrombophilia
06/2011 - 01/2004
3Thrombocytopenia (Thrombopenia)
09/2006 - 01/2002
1Necrosis
06/2014
1Rheumatic Diseases (Rheumatism)
01/2014
1Venous Thrombosis (Deep-Vein Thrombosis)
12/2013
1Atherosclerosis
05/2013
1Vascular System Injuries
10/2009
1Infections
01/2003
1Communicable Diseases (Infectious Diseases)
01/2003
1Opportunistic Infections (Opportunistic Infection)
08/2002
1Neoplasms (Cancer)
08/2002

Drug/Important Bio-Agent (IBA)

17Antiphospholipid AntibodiesIBA
09/2016 - 02/2002
14AntibodiesIBA
09/2016 - 01/2002
10Immunoglobulin G (IgG)IBA
04/2015 - 08/2002
7Thromboplastin (Tissue Factor)IBA
04/2015 - 10/2007
5Monoclonal AntibodiesIBA
01/2014 - 01/2004
5Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA
05/2013 - 09/2006
4Glycoproteins (Glycoprotein)IBA
09/2016 - 01/2011
4Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
04/2013 - 09/2006
3Hydroxychloroquine (Plaquenil)FDA LinkGeneric
09/2006 - 03/2002
3Peptides (Polypeptides)IBA
05/2004 - 02/2002
2Immunoglobulin A (IgA)IBA
09/2016 - 12/2013
2Antigen-Antibody Complex (Immune Complex)IBA
01/2016 - 01/2011
2Proteins (Proteins, Gene)FDA Link
12/2014 - 06/2014
2AutoantibodiesIBA
01/2014 - 08/2002
2Anticardiolipin AntibodiesIBA
06/2012 - 04/2008
2Immunoglobulin M (IgM)IBA
01/2012 - 06/2007
2beta 2-Glycoprotein I (Apolipoprotein H)IBA
10/2009 - 04/2008
2FluvastatinFDA Link
09/2009 - 11/2003
2Complement System Proteins (Complement)IBA
07/2005 - 06/2005
1LipidsIBA
01/2016
1AldehydesIBA
01/2016
1Phospholipids (Phosphatides)FDA LinkGeneric
04/2015
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2014
1InterferonsIBA
06/2014
1InterleukinsIBA
06/2014
1CD40 Ligand (CD40L)IBA
06/2014
1Biomarkers (Surrogate Marker)IBA
06/2014
1Immunoglobulins (Immunoglobulin)IBA
01/2014
1AntigensIBA
01/2014
1low density lipoprotein receptor-related protein 8IBA
01/2011
1Free RadicalsIBA
07/2010
1NF-kappa B (NF-kB)IBA
06/2010
1p38 Mitogen-Activated Protein KinasesIBA
06/2010
1AutoantigensIBA
04/2008
1LipopolysaccharidesIBA
10/2007
1Toll-Like Receptor 4IBA
10/2007
1Toll-Like Receptors (Toll-Like Receptor)IBA
10/2007
1Complement Membrane Attack Complex (Membrane Attack Complex)IBA
06/2007
1Anaphylatoxin C5a ReceptorIBA
06/2007
1Complement C3 (C3 Complement)IBA
07/2005
1CoagulantsIBA
06/2005
1Bacterial AntigensIBA
05/2004
1peptide AIBA
05/2004
1B-Cell Activating FactorIBA
08/2002
1Antimalarials (Antimalarial Agents)IBA
03/2002

Therapy/Procedure

6Therapeutics
01/2012 - 01/2004
3Operative Surgical Procedures
12/2013 - 05/2004
2Injections
10/2009 - 07/2005
1Transcranial Direct Current Stimulation
11/2014